Kanavape ruling could kick-start French CBD industry – but not everyone’s happy

Written by CBD-Intel || 3rd December 2020 || Business briefing |

EU

Europe

France

EU regulation

Policy and Politics

Business briefing

The decision by the Court of Justice of the European Union (CJEU) in the Kanavape cape that CBD cannot be treated as a narcotic has been welcomed in France – though not by the official regulatory bodies ...

Regulatory tracker: how 50 different countries regulate CBN and CBG

Written by CBD-Intel || 3rd December 2020 || Regulatory trackers |

Regulation and Legislation

Regulatory trackers

This tracker sets out to guide you though the legal status and classification of two of the most popular cannabinoids, after CBD and THC, in 50 selected countries ...

Proposal put forward in yet another attempt to regulate the Italian CBD sector

Written by CBD-Intel || 27th November 2020 || Regulatory briefing |

Europe

Italy

Regulation and Legislation

Regulatory briefing

Italian legislators have put forward another proposal that has yet to be presented as an amendment to regulate the CBD sector and, in particular, the sale of flowers, finished products and extracts ...

CBD-Intel regulatory news in brief, 21st-27th November

Written by CBD-Intel || 27th November 2020 || Alerts roundup |

Africa

Asia

Belgium

California

EU

Europe

France

Georgia

Germany

Iowa

Israel

Italy

Lithuania

Netherlands

New Jersey

North America

North Carolina

Poland

South Africa

South Dakota

Spain

Thailand

United States

Zimbabwe

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief includes updates from the EU, Belgium, France, Germany, Italy, Lithuania, Netherlands, Poland, Spain, the US, Israel, South Africa, Thailand and...

What impact will Black Friday sales have on the CBD sector?

Written by CBD-Intel || 27th November 2020 || Blog |

World

Companies

Health

Marketing and Retailing

Policy and Politics

Regulation and Legislation

Technology and Innovation

Blog

Overall it seems the industry – particularly in Europe – is not expecting much from Black Friday sales. European companies appear to consider CBD products more as health products that are requirement purchases throughout the year as opposed to lifestyle products that might be...

Malawi accused of setting licence fees to exclude local farmers’ ownership

Written by CBD-Intel || 25th November 2020 || Regulatory briefing |

Africa

Malawi

Farming

Policy and Politics

Regulation and Legislation

Regulatory briefing

Officials in Malawi have been accused of deliberately setting high licence fees for hemp and cannabis cultivation and trade in order to attract international investment and exclude local ownership ...

CBD-Intel regulatory news in brief, 14th-20th November

Written by CBD-Intel || 20th November 2020 || Alerts roundup |

Africa

Asia

Brazil

California

China

Costa Rica

Czech Republic

EU

Europe

France

Kansas

Kentucky

Minnesota

Namibia

Netherlands

New Jersey

North America

North Carolina

Oklahoma

South America

Spain

Switzerland

United Kingdom

United Kingdom

United States

Virginia

West Virginia

Wisconsin

Wyoming

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief includes updates from the EU, Czech Republic, France, Netherlands, Spain, Switzerland, the UK, Mexico, the US, Cayman Islands, Brazil, China Costa Rica and Namibia ...

How important is the CJEU decision on the Kanavape case?

Written by CBD-Intel || 20th November 2020 || Blog |

Europe

Companies

Health

Policy and Politics

Regulation and Legislation

Technology and Innovation

Blog

How important is the CJEU decision on the Kanavape case?  The judgement in favour of CBD from the Courts of Justice of the European Union (CJEU) will almost certainly have significant long-term consequences for the CBD industry in Europe....

Aurora closes overnight offering in continued attempts to raise funds

Written by CBD-Intel || 20th November 2020 || Business briefing |

Canada

North America

Companies

Business briefing

Aurora Cannabis continues to raise money and issue shares, despite facing allegations of misleading statements in a class-action lawsuit filed by investors ...

A comparative analysis of state laws in the US

Written by CBD-Intel || 19th November 2020 || Presentations , Resources |

North America

United States

Companies

Food

Regulation and Legislation

Technology and Innovation

US federal regulation

Presentations

Resources

Berta Camps Bisbal, CBD-Intel’s senior legal analyst, presented a comparative analysis of state laws in the US at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 18th November. She presented an overview of the...

Biden’s election should be good news for cannabis legalisation – eventually

Written by CBD-Intel || 18th November 2020 || Regulatory briefing |

North America

United States

Policy and Politics

US federal regulation

Regulatory briefing

With Joe Biden poised to become the 46th US president, lobbyists in Washington are scrambling to position themselves to influence cannabis policy ...

The good, the bad and the troublesome – could CBD and nicotine make a match?

Written by CBD-Intel || 17th November 2020 || Business briefing |

North America

United States

Companies

Health

Technology and Innovation

Vapour/Smokable

Business briefing

CBD, generally seen as a health or wellness product, and “bad guy” nicotine are almost opposites in terms of public perception – but could putting the two together make commercial sense? ...

Where are we most likely to see changes to medical and recreational cannabis regimes?

Written by CBD-Intel || 13th November 2020 || Blog |

World

Companies

Health

Policy and Politics

Regulation and Legislation

Blog

Mexico is overall the number one country to watch, rated highly likely to change regulations on both medical and recreational cannabis in the near...

CBD-Intel regulatory news in brief, 7th-13th November

Written by CBD-Intel || 13th November 2020 || Alerts roundup |

Argentina

Asia

Australasia

Australia

Belgium

California

China

Colombia

Costa Rica

EU

Europe

Germany

Illinois

Israel

Missouri

Montana

New Jersey

New York

New Zealand

North America

South America

Spain

Ukraine

United Kingdom

United States

Washington

Wyoming

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief includes updates from the EU, Germany, Belgium, Spain, the UK, Mexico, the US, Argentina, Colombia, Costa Rica, Israel and...

Ukraine moves towards potential medical cannabis legalisation

Written by CBD-Intel || 13th November 2020 || Regulatory briefing |

Europe

Ukraine

Regulation and Legislation

Regulatory briefing

Ukraine has undergone a quick shift in opinion on medical cannabis – proceeding from a point where liberalisation of current laws was viewed as unlikely to setting up parliamentary working groups to draft a bill on legalisation ...

Raided German firm expects to get its vending machines back, minus flowers

Written by CBD-Intel || 13th November 2020 || Business briefing |

Europe

Germany

Retail

Business briefing

The sale of CBD products through vending machines in the German state of Bavaria is likely to continue after operators remove hemp flower products ...

Questions in Poland as CBD vending machines attract police attention

Written by CBD-Intel || 12th November 2020 || Business briefing |

Europe

Poland

Retail

Business briefing

Concerns over youth access could curtail growing interest in CBD vending machines in Poland, with police and other authorities taking an interest in unsupervised sales ...

Cannabis sector consolidates as investors join second rush for ‘green gold’

Written by CBD-Intel || 11th November 2020 || Business briefing |

North America

United States

Companies

US federal regulation

Business briefing

Investing activity in the cannabis space is on the rise, as investors take advantage of lower prices and companies seek opportunities to merge – bolstered by anticipated changes at US federal level ...

CBD suffering reputational damage from FDA probe and reports of bad labelling

Written by CBD-Intel || 10th November 2020 || Business briefing |

North America

United States

US federal regulation

Business briefing

Well reported studies of labelling issues give unfair bad press to CBD – but it is an issue the industry urgently needs to address, according to speakers at the Food and Drug Law Institute’s annual conference ...

Will US FDA ever publish its guidance on CBD enforcement? Who knows when?

Written by CBD-Intel || 9th November 2020 || Business briefing |

North America

United States

US federal regulation

Business briefing

It remains unclear when, or whether, US FDA guidance on CBD enforcement policy will be published, according to speakers at the recent Food and Drug Law Institute annual conference ...

Regulatory report: medical and recreational cannabis – a global overview

Written by CBD-Intel || 9th November 2020 || Regulatory reports |

Africa

Asia

Australasia

Australia

Austria

Belgium

Brazil

Bulgaria

Canada

Chile

China

Colombia

Croatia

Czech Republic

Denmark

Europe

Finland

France

Germany

Greece

Hong Kong

Hungary

India

Ireland

Israel

Italy

Japan

Latvia

Lithuania

Malaysia

Mexico

Netherlands

New Zealand

North America

Norway

Peru

Poland

Portugal

Romania

Russia

Serbia

Singapore

Slovenia

South Africa

South America

South Korea

Spain

Sweden

Switzerland

Taiwan

Thailand

Turkey

Ukraine

United Kingdom

United States

Uruguay

World

Regulation and Legislation

Regulatory reports

CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries ...

Italian health ministry suspends its decree defining oral CBD as medication

Written by CBD-Intel || 6th November 2020 || Regulatory briefing |

Europe

Italy

Food

Policy and Politics

Regulation and Legislation

Regulatory briefing

The Italian Ministry of Health has suspended the recently published decree listing oral administration of CBD as a medicine under Italy’s Narcotics Law ...

CBD-Intel regulatory news in brief, 31st October-6th November

Written by CBD-Intel || 6th November 2020 || Alerts roundup |

Argentina

Asia

Australasia

Australia

China

Costa Rica

Europe

France

Germany

Israel

Lithuania

New Jersey

New York

New Zealand

North America

Ohio

Russia

South America

United Kingdom

United Kingdom

United States

World

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief includes updates from France, Germany, Lithuania, the UK, the US, Argentina, Australia, China, Costa Rica, Guyana, Israel, New Zealand, Panama, Russia and Uruguay ...

US voters in another five states give thumbs up to legalising cannabis

Written by CBD-Intel || 5th November 2020 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

One in three US citizens will soon be living in states where recreational cannabis is legal, while around 70% will have access to some form of medical cannabis programme after voters had their say ...

Little fear of a glut in the UK market if EU decides to classify CBD as a narcotic

Written by CBD-Intel || 3rd November 2020 || Business briefing |

EU

Europe

United Kingdom

Companies

EU regulation

Business briefing

Companies do not feel much risk of a glut of CBD-containing food, drink and dietary supplement products or cannabinoid ingredients coming into the UK market if the EU classifies CBD as a narcotic ...

CBD-Intel global alerts database November

Written by CBD-Intel || 3rd November 2020 || Alerts roundup |

Afghanistan

Africa

Alabama

Alaska

Albania

Algeria

Andorra

Argentina

Arizona

Arkansas

Armenia

Armenia

Asia

Australasia

Australia

Austria

Bahrain

Bangladesh

Belarus

Belgium

Bosnia and Herzegovina

Brazil

Bulgaria

California

Cambodia

Canada

Chile

China

Colombia

Colorado

Connecticut

Croatia

Cyprus

Czech Republic

Delaware

Democratic Republic of the Congo

Denmark

Ecuador

Egypt

England

Estonia

Ethiopia

EU

Europe

Finland

Florida

France

Georgia

Georgia

Germany

Greece

Hawaii

Honduras

Hong Kong

Hungary

Iceland

Idaho

Illinois

India

Indiana

Indonesia

Iowa

Iran

Iraq

Ireland

Isle of Man

Israel

Italy

Japan

Kansas

Kazakhstan

Kentucky

Kenya

Kosovo

Kuwait

Kyrgyzstan

Latvia

Lesotho

Libya

Lithuania

Louisiana

Luxemburg

Macedonia

Maine

Malaysia

Malta

Maryland

Massachusetts

Mauritania

Mexico

Michigan

Middle East

Minnesota

Mississippi

Missouri

Moldova

Monaco

Montana

Montenegro

Morocco

Mozambique

Myanmar

Namibia

Nebraska

Nepal

Netherlands

Nevada

New Hampshire

New Jersey

New Mexico

New York

New Zealand

Nigeria

North America

North Carolina

North Dakota

North Korea

Northern Ireland

Norway

Ohio

Oklahoma

Oman

Oregon

Pakistan

Paraguay

Pennsylvania

Peru

Philippines

Poland

Portugal

Puerto Rico

Qatar

Rhode Island

Romania

Russia

San Marino

Saudi Arabia

Scandinavia

Scotland

Serbia

Singapore

Slovakia

Slovenia

South Africa

South America

South Carolina

South Dakota

South Korea

Spain

Sri Lanka

Sudan

Sweden

Switzerland

Syria

Taiwan

Tanzania

Tennessee

Texas

Thailand

Tunisia

Turkey

Uganda

Ukraine

United Arab Emirates

United Kingdom

United States

Uruguay

Utah

Uzbekistan

Vatican City

Venezuela

Vermont

Vietnam

Virginia

Wales

Washington

Washington D.C.

West Virginia

Wisconsin

World

Wyoming

Yemen

Zimbabwe

Policy and Politics

Regulation and Legislation

Alerts roundup

All the stories from the CBD-Intel weekly global regulatory Live Alerts in one user-friendly database, updated every month. This regulatory tool consolidates all of our global regulatory Live Alerts since they were launched in May 2019, collected in Excel...

CBD-Intel regulatory news in brief, 24th-30th October

Written by CBD-Intel || 30th October 2020 || Alerts roundup |

Argentina

Asia

Australasia

California

China

Colorado

EU

Europe

Idaho

Ireland

Isle of Man

Israel

Italy

Kentucky

Mexico

New York

New Zealand

North America

Peru

South America

Spain

Texas

Ukraine

United Kingdom

United Kingdom

United States

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief includes updates from the EU, Ireland, Italy, Spain, the UK, Dominica, Mexico, the US, Argentina, China, Israel, New Zealand, Peru and Ukraine ...

What impact could the vote to support a 0.3% THC limit in hemp varieties have on the CBD market in the short-term?

Written by CBD-Intel || 30th October 2020 || Blog |

Europe

Switzerland

Companies

Policy and Politics

Regulation and Legislation

Retail

Blog

In short – not a lot in the short-term. The vote in favour of a 0.3% THC limit by the European Parliament (EP) is only the first step in a long process towards actually putting such a change into...

No plans to ease restrictions on flowers, says UK Home Office

Written by CBD-Intel || 29th October 2020 || Regulatory briefing |

Europe

United Kingdom

EU regulation

Regulation and Legislation

Regulatory briefing

The UK Home Office has stated it has no plans to ease restrictions on using flowers for extraction before the EU exit transition period ends on 1st January 2021 ...

Funding and support promised for hemp sector development in Yunnan

Written by CBD-Intel || 29th October 2020 || Regulatory briefing |

Asia

China

Regulation and Legislation

Regulatory briefing

A CNY5bn ($745m) fund and three years of CNY100m ($14.9m) funding have been promised as part of a hemp sector development plan for Kunming City, the capital of Yunnan Province ...

Black Friday novelty diminishes to make way for longer sales period

Written by CBD-Intel || 27th October 2020 || Business briefing |

Europe

North America

United Kingdom

United States

Companies

Marketing and Retailing

Business briefing

Holiday sales overall mean more to US companies than their UK counterparts, but the novelty of Black Friday means some are embracing a discount period as a means to create new sales, according to a number of companies...

Italian vape stores prohibited from selling CBD products

Written by CBD-Intel || 26th October 2020 || Regulatory briefing |

Europe

Italy

Regulation and Legislation

Regulatory briefing

Italian vape stores will not be able to sell CBD products following the publication of a circular ...

CBD-Intel regulatory news in brief, 17th-23rd October

Written by CBD-Intel || 23rd October 2020 || Alerts roundup |

Australasia

Australia

Czech Republic

EU

Europe

France

Germany

Ireland

Italy

Michigan

New York

New Zealand

North America

Tennessee

Ukraine

United States

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief includes updates from the Czech Republic, EU, France, Germany, Ireland, Italy, the US, Australia, Colombia, Ecuador, New Zealand and Ukraine ...

CBD and hemp regulation: confusion in the US

Written by CBD-Intel || 23rd October 2020 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

Regulation of CBD at the federal level remains confusingly divided between multiple agencies. Three main bodies have overall control of most aspects of hemp and CBD consumer product regulation ...

CBD and hemp regulation: the US DEA and its authority

Written by CBD-Intel || 23rd October 2020 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The passage of the 2018 Farm Bill removed hemp and compounds derived from hemp (including CBD) from the CSA. Therefore, the DEA should have very little involvement in enforcing laws and regulations on hemp and CBD ...

CBD and hemp regulation: the US FDA and its authority

Written by CBD-Intel || 23rd October 2020 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The US Food and Drug Administration (FDA) is a critical agency in the regulatory scheme of CBD products. The 2018 Farm Bill, which legalised hemp and CBD derived from it, granted the FDA the authority to regulate hemp...

CBD and hemp regulation: the USDA and its authority

Written by CBD-Intel || 23rd October 2020 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

Among the most important obligations delegated to it in the Farm Bill, the USDA is responsible for rule making regarding production and testing of hemp and approving state and tribal plans for hemp production ...

What impact could a decision in the recent Dusseldorf lawsuit have on the German CBD sector?

Written by CBD-Intel || 23rd October 2020 || Blog |

Europe

Germany

Companies

Food

Regulation and Legislation

Blog

The company of the president of the European Industrial Hemp Association (EIHA) has challenged a ban on the sale of all foods containing...

Nestlé enters European CBD market with soft gel capsules

Written by CBD-Intel || 23rd October 2020 || Business briefing |

Europe

United Kingdom

Companies

Business briefing

Nestlé has taken a baby step into the European cannabidiol market just a year after creating its own CBD line in the US and will now distribute soft gel CBD capsules in the UK through the Pure Encapsulations...

Ministerial decree causes further confusion for the Italian market

Written by CBD-Intel || 22nd October 2020 || Regulatory briefing |

Europe

Italy

Regulation and Legislation

Regulatory briefing

A ministerial decree listing oral administration of CBD as a medicine under Italy’s Narcotics Law is meant to clear the way for the introduction of Epidyolex into the market, not to prevent consumer wellness products being sold...

Podcast: global CBD markets and their commonalities and differences

Written by CBD-Intel || 22nd October 2020 || Podcasts , Resources |

World

Companies

Market Research

Marketing and Retailing

Regulation and Legislation

Podcasts

Resources

Our host for today’s podcast is Jon Bruford, a copy editor at CBD-Intel, who will be joined by CBD-Intel market analyst Maria Alejandra Estanga, who analyses the CBD market for European and American countries. In CBD-Intel’s new podcast,...

COVID-19: emergency regulations and affected legislative procedures

Written by CBD-Intel || 20th October 2020 || Alerts roundup |

COVID-19

Health

Regulation and Legislation

Alerts roundup

Find all of CBD-Intel’s coronavirus-related regulatory alerts here, updated as they appear ...

Lobbyists hard at work for regulatory change as US elections approach

Written by CBD-Intel || 19th October 2020 || Regulatory briefing |

North America

United States

Policy and Politics

US federal regulation

Regulatory briefing

With US elections on 3rd November fast approaching, lobbyists for CBD, cannabis and hemp are eager to get their message across to candidates on both sides of the political divide ...

CBD-Intel regulatory news in brief, 10th-16th October

Written by CBD-Intel || 19th October 2020 || Alerts roundup |

Africa

Argentina

Asia

Australasia

Australia

Belgium

Canada

Connecticut

EU

Europe

France

Germany

Israel

Italy

Maryland

Mexico

Michigan

Mississippi

New York

New Zealand

Nigeria

North America

South Africa

South America

South Dakota

Switzerland

Ukraine

United Kingdom

United States

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief includes updates from the EU, Belgium, France, Germany, Italy Switzerland, the UK, Canada, Mexico, the US, Argentina, Australia, Israel, New Zealand, Nigeria, Rwanda, South Africa and...

What impact will the US elections have on CBD and cannabis?

Written by CBD-Intel || 16th October 2020 || Blog |

North America

United States

Food

Policy and Politics

Regulation and Legislation

Blog

It's important to remember that all aspects of cannabis and CBD – even federal decriminalisation or legalisation...

Red yeast rice and stem cells could point the way ahead for FDA regulation of CBD

Written by CBD-Intel || 16th October 2020 || Regulatory briefing |

North America

United States

Food

US federal regulation

Regulatory briefing

The apparently unrelated fields of red yeast rice and stem cell research could provide clues as to how the US Food and Drug Administration (FDA) might deal with market regulation of CBD ...

Regulatory report: Australia

Written by CBD-Intel || 15th October 2020 || Regulatory reports |

Australasia

Australia

Regulation and Legislation

Regulatory reports

CBD is listed on the Controlled Drug Register in Australia, which means it cannot be sold as a consumer product. This report offers an overview of the current regulatory framework in the country for CBD ...

CBD ads spring up at Serie A football grounds as Italy takes to home delivery

Written by CBD-Intel || 13th October 2020 || Business briefing |

Europe

Italy

Companies

COVID-19

Retail

Business briefing

Matches in Serie A, the top football league in Italy, are for the first time featuring advertisements for a CBD company as the home delivery market continues to grow rapidly in the country ...

CBD-Intel regulatory news in brief, 3rd-9th October

Written by CBD-Intel || 9th October 2020 || Alerts roundup |

Asia

Australasia

Australia

Austria

California

Colombia

Europe

France

Germany

Hawaii

Israel

Italy

Lebanon

Nebraska

Netherlands

New Zealand

North America

Romania

Russia

Slovakia

South America

Spain

Ukraine

United Kingdom

United States

Vermont

World

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief includes updates from the EU, Austria, France Germany, Italy, the Netherlands, Slovakia, Romania, Spain, the UK, the US, Australia, Colombia, Israel, Lebanon, New Zealand, Russia and Ukraine ...

Costa Rica looks set to legalise hemp and medical cannabis production

Written by CBD-Intel || 9th October 2020 || Regulatory briefing |

Costa Rica

South America

Regulation and Legislation

Regulatory briefing

A Costa Rican bill legalising the production of hemp and medical cannabis looks likely to pass due to broad support from the ruling coalition and president ...